|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
JOIN THE WEBINAR – MARCH 30, 10 AM US EDT |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mobile Health: Managing the Process to Realize the Benefits
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patients are engaging with technology in ways that can produce longitudinal data measures and generate more powerful data analytics possibilities. However, regulatory expertise and planning in an evolving area of health care remains a critical need.
Join
this webinar to learn about the scope of changes in mobile health device regulation and the considerations for validating your device.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
William Hanlon, PhD
Vice President, Head of Global Regulatory Affairs, Covance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
REALIZE THE PROMISE AND POTENTIAL OF MOBILE HEALTH
|
|
|
|
|
|
|
|
|
|
|
|
|
Scott Thiel, MBA, MT (ASCP), RAC
Associate Director, Navigant Consulting, Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Covance Inc., headquartered in Princeton, NJ, USA is the drug development
business of Laboratory Corporation of America Holdings (LabCorp).
COVANCE is a registered trademark and the marketing name for Covance Inc.
and its subsidiaries around the world.
Copyright © 2016 Covance Inc. All rights reserved.
To opt out of future Covance correspondence, please click here.
Covance Inc., 210 Carnegie Center Princeton, NJ 08540-6233 USA
THE AMERICAS: +1.888.COVANCE (+1.888.268.2623) +1.609.452.4440
EUROPE/AFRICA: +00.800.2682.2682 +44.1423.500888
ASIA PACIFIC: +800.6568.3000 +65.6.5686588 |